Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Clinical trial NCT07621692 · RECRUITING

Trial details

NCT number: NCT07621692
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Start date: 2026-01-01
Primary completion: 2030-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.